Cargando…
On the utilization of polygenic risk scores for therapeutic targeting
The promise of personalized genomic medicine is that knowledge of a person’s gene sequences and activity will facilitate more appropriate medical interventions, particularly drug prescriptions, to reduce the burden of disease. Early successes in oncology and pediatrics have affirmed the power of pos...
Autor principal: | Gibson, Greg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483161/ https://www.ncbi.nlm.nih.gov/pubmed/31022172 http://dx.doi.org/10.1371/journal.pgen.1008060 |
Ejemplares similares
-
Risk Stratification and Clinical Utility of Polygenic Risk Scores in Ophthalmology
por: Qassim, Ayub, et al.
Publicado: (2021) -
Post‐GWAS Polygenic Risk Score: Utility and Challenges
por: Nguyen, Tuan V, et al.
Publicado: (2020) -
Utility of Polygenic Risk Scoring to Predict Cognitive Impairment as Measured by Preclinical Alzheimer Cognitive Composite Score
por: Gao, Q., et al.
Publicado: (2022) -
The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review
por: Kumuthini, Judit, et al.
Publicado: (2022) -
The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
por: Sud, Amit, et al.
Publicado: (2021)